Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaccination response after rituximab-containing therapy in lymphoma patients
NL-OMON32777Withdrawn
- Sponsor
- St. Antonius Ziekenhuis
- Start
- Mar 2009
- Modality
- Vaccines & Immunotherapeutics, Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of pneumococcal 7-valent conjugate vaccine, haemophilus influenzae type b vaccine, influenza vaccine and 23-valent pneumococcal polysaccharide vaccine in pneumococcal disease, Haemophilus influenzae type b disease (Hib) and influenza, sponsored by St. Antonius Ziekenhuis. Primary endpoints: Antibody titres against Streptococcus pneumoniae, Antibody titres against Haemophilus influenzae type b and 2 more. Planned start Mar 2009; status: withdrawn.
02
Drugs
pneumococcal 7-valent conjugate vaccinehaemophilus influenzae type b vaccineinfluenza vaccine23-valent pneumococcal polysaccharide vaccine
03
Conditions
pneumococcal diseaseHaemophilus influenzae type b disease (Hib)influenza
Beyond the preview
Go deeper on NL-OMON32777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON32777.